跳至主要内容
临床试验/ISRCTN13103571
ISRCTN13103571进行中(未招募)未知

Molecular Characterization and Clinical Aspects of Germline TP53 Mutations in the Swedish Constitutional TP53 Cohort.

Stockholms Läns Landsting0 个研究点目标入组 60 人开始时间: 2019年10月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

2019 Abstract results in https://www.abstractsonline.com/pp8/#!/7874/presentation/3031 conference abstract (added 11/10/2019) 2020 Other publications in https://pubmed.ncbi.nlm.nih.gov/31956380/ rationale and design (added 19/04/2021) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36601958/ cancer worry, perceived benefits and risks to surveillance and overall health (added 07/11/2023) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35053544/ sub-study of WB-MRI findings generated by the baseline examination (added 07/11/2023)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. All carriers of a pathogenic TP53 germline variant over the age of 15 years OR all children (0-18 years) who have 50% risk of inheriting a pathogenic TP53 germline variant
  • 2. Able to provide informed consent

排除标准

  • 1. Individuals with a TP53 germline variant of unknown pathogenicity

研究者

发起方
Stockholms Läns Landsting

相似试验

nderstanding the genetic causes and clinical aspects... | 临床试验